Further proteome and transcriptome analyses of monocytes in patients with mild disease revealed an increase in the proportion of activated classical monocytes with the CD14+HLA-DRhiCD11hi phenotype (HLA-DRAhiCD83hi), which were absent in both the severe COVID-19 and control groups [45]. Here, CD14 is linked to COVID-19.